These results will improve our knowledge of AC3, lead to a more comprehensive understanding of the mechanisms underlying the physiological effects of liraglutide on obesity and provide prospects for new therapeutic interventions for human obesity disorders. This evidence concerns the gene ADCY3 and Obesity.